EPS

With a $1.2B war chest from its Aerospace sale, TriMas boosts profits and shareholder returns. A closer look reveals the next phase of its reinvention.

Altria touts shareholder returns and narrows profit guidance, but a deeper look reveals weakening Marlboro sales and a high-stakes, uncertain pivot to smoke-free.

Amid record revenues, Martin Marietta's blockbuster deal for Lhoist North America signals a bold pivot beyond construction into industrial minerals.

As Dollar General preps its Q2 earnings, all eyes are on what its results will reveal about inflation, consumer shifts, and the health of the U.S. economy.

Gildan Activewear leverages its HanesBrands integration for a strong Q2, divesting assets to cut debt while reinvesting a tariff windfall into innovation.

The chocolate giant posted staggering Q2 earnings growth, but a closer look reveals a risky strategy of hiking prices that is eroding sales volumes.

Europe's top logistics developer CTP leverages record leasing and CEE market strength to fund a strategic leap into Vietnam, navigating financial headwinds.

Cactus Inc. crushed Q2 estimates and boosted its dividend by 7%, signaling deep confidence. A closer look reveals how its Spoolable Tech and strategic global expansion are creating a resilient growth engine.

Nebraska's Central Plains Bancshares plans a major stock buyback, signaling confidence. But with an activist investor pushing, is this a bold strategy or a forced hand?

Alerus reports strong Q2 earnings, driven by a resilient diversified model and a dramatic 68% reduction in nonperforming assets, boosting shareholder returns.

After a major Q4 earnings miss, all eyes are on Universal Corp's upcoming call. Can it justify its dividend and prove its strategic pivot is working?

Vistra's latest dividend signals financial stability, but a closer look reveals a strategic blueprint for navigating the complex energy transition.

Antero Midstream posts record operational growth and a key legal win, yet its stock stumbles. A deep dive into the numbers reveals a complex strategy.

As Hamilton Beach sets its Q2 earnings call, the focus is less on kitchen gadgets and more on its strategic pivot into healthcare and commercial markets.

As Hyperion DeFi (HYPD) preps its Q2 report, the market awaits a first look into the viability of a publicly-traded company built on a DeFi protocol.

As Akebia Therapeutics preps its Q2 report, all eyes are on Vafseo's uptake, a declining Auryxia, and a costly R&D push into rare kidney diseases.

With a history of beating expectations and a new acquisition in tow, all eyes are on Calian's Q3 results to see if its mission-critical strategy can sustain momentum.

Kirby Corporation's latest earnings reveal a powerful strategy: pairing the steady might of inland barges with the surging demand for data center power.

Beyond a stellar earnings beat, The Chefs' Warehouse Q2 results reveal a powerful strategy of operational leverage and deep market penetration in high-end dining.

With Q2 earnings soaring and its outlook raised, Bunge is proving its Viterra merger was a strategic masterstroke, creating an agile giant in a volatile world.